Greenfield S, Sullivan L, Dukes K A, Silliman R, D'Agostino R, Kaplan S H
Primary Care Outcomes Research Institute, New England Medical Center, Boston, MA 02111, USA.
Med Care. 1995 Apr;33(4 Suppl):AS47-55.
Case mix has been shown to be of critical importance in studies of effectiveness and quality of care using health outcomes. How these variables are defined, combined, and used to adjust or increase precision in tests for differences in health outcomes has been a source of controversy. Because existing measures were developed to adjust mortality and have marginal relevance for the adjustment of functional status outcomes, especially in ambulatory settings, the authors developed a measure of case (or patient) mix that is specifically designed to adjust functional status outcomes measured in office practice or out-of-hospital settings. This measure, developed as part of Type II Diabetes Patient Outcomes Research Team project, uses patients' reports of symptoms and conditions, as well as patients' ratings of symptom intensity to characterize total disease burden. It differs from other measures of case mix in lack of dependence on diagnoses. Separate measures were developed for each of 15 different disease categories (e.g., chronic lung disease) grouped by body system affected. Within each measure, questionnaire items were combined to rate the severity of that disease on a 1 to 4 scale, according to definitions provided by clinicians. A single, global measure was developed by aggregating the 15 measures, weighted according to the expected impact of each disease category on functional outcomes and disability. In a sample of 1,738 patients, significant relationships were observed between the global case mix measure and functional status, disability days, and service utilization.(ABSTRACT TRUNCATED AT 250 WORDS)
病例组合在使用健康结局的医疗有效性和质量研究中已被证明至关重要。这些变量如何定义、组合以及用于调整或提高健康结局差异测试的精度一直是争议的根源。由于现有措施是为调整死亡率而制定的,对功能状态结局的调整相关性不大,尤其是在门诊环境中,作者开发了一种病例(或患者)组合测量方法,专门用于调整在门诊实践或院外环境中测量的功能状态结局。作为II型糖尿病患者结局研究团队项目的一部分开发的这项测量方法,使用患者的症状和病情报告以及患者对症状强度的评分来表征总疾病负担。它与其他病例组合测量方法的不同之处在于不依赖诊断。针对按受影响身体系统分组的15种不同疾病类别(如慢性肺病)分别开发了测量方法。在每种测量方法中,根据临床医生提供的定义,将问卷项目组合起来,以1至4级对该疾病的严重程度进行评分。通过汇总这15种测量方法,根据每种疾病类别对功能结局和残疾的预期影响进行加权,开发了一个单一的综合测量方法。在1738名患者的样本中,观察到综合病例组合测量方法与功能状态、残疾天数和服务利用之间存在显著关系。(摘要截短为250字)